Efficacy of Interferon- β in Moderate-to-Severe Hospitalised Cases of COVID-19: A Systematic Review and Meta-analysis

ConclusionAddition of interferon- β to standard of care resulted in significant reduction in time to clinical improvement but no significant benefit in terms of reduction in mortality and length of hospital stay in moderate-to-severe cases of COVID-19.
Source: Clinical Drug Investigation - Category: Drugs & Pharmacology Source Type: research